APP and Alzheimer disease: A study performed in the APP-PS1 mouse model of AD showed that chronic blockade of the calcium channel TRPA1 was sufficient to normalize astrocytic activity, avoid perisynaptic astrocytic process withdrawal, prevent neuronal dysfunction and preserve structural synaptic integrity, thus preserving spatial working memory in that model.